Takashi Babasaki

548 citations
31 papers · 318 indexed · h-index 12

Takashi Babasaki

29 papers receiving 316 citations

Peers

Takashi Babasaki
Comparison fields: 5 of 56
  • Cancer Research 88
  • Pulmonary and Respiratory Medicine 133
  • Oncology 85
  • Molecular Biology 184
  • Biological Psychiatry 4
Replace Shengmeng Peng with:
Shengmeng Peng China
Heather Herrington United States
Elyse L. Walk United States
Hwa-Ryeon Kim South Korea
Frank Duong United States
Maithili P. Dalvi United States
Bitian Liu China
Camille Derderian United States
Carolyn J. Vivian United States
Tracy L. Krebs United States
Takashi Babasaki relative to Shengmeng Peng China Shengmeng Peng's profile →
Citations per field
00.5×1.5×2.3×
Shengmeng Peng · 1×
Citations per year

Countries citing papers authored by Takashi Babasaki

Since Specialization
Citations

This map shows the geographic impact of Takashi Babasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Babasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Babasaki more than expected).

Fields of papers citing papers by Takashi Babasaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Babasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Babasaki. The network helps show where Takashi Babasaki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Takashi Babasaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Takashi Babasaki Line = papers co-authored together Takashi Babasaki links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20240
3 20233
4 20237
5 20232
6 20222
7 20222
8 20225
9 202113
10 202112
11 202123
12 202111
13 20219
14 20217
15 202110
16 202018
17 202025
18 202021
19 20202
20 202022

About Takashi Babasaki

Takashi Babasaki is a scholar working on Pulmonary and Respiratory Medicine, Urology and Biological Psychiatry, having authored 31 papers that have together received 318 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (15 papers), Bladder and Urothelial Cancer Treatments (9 papers), Epigenetics and DNA Methylation (7 papers), Ferroptosis and cancer prognosis (6 papers), Prostate Cancer Treatment and Research (6 papers), Renal and related cancers (5 papers), Urinary and Genital Oncology Studies (5 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Cancer Research (88 citations), Pulmonary and Respiratory Medicine (133 citations) and Oncology (85 citations). Takashi Babasaki has collaborated with scholars based in Japan, United States and Vietnam. Frequent co-authors include Yohei Sekino, Tetsutaro Hayashi, Wataru Yasui, Jun Teishima, Kazuhiro Sentani, Akio Matsubara, Keisuke Goto, Shogo Inoue, Naohide Oue and Go Kobayashi. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026